Zai Lab Ltd (ZLAB)
27.20
-2.74
(-9.15%)
USD |
NASDAQ |
Nov 14, 13:08
Zai Lab Shareholders Equity (Quarterly): 704.18M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 704.18M |
March 31, 2024 | 762.17M |
December 31, 2023 | 796.12M |
September 30, 2023 | 880.98M |
June 30, 2023 | 932.31M |
March 31, 2023 | 1.001B |
December 31, 2022 | 1.046B |
September 30, 2022 | 1.106B |
June 30, 2022 | 1.212B |
March 31, 2022 | 1.308B |
December 31, 2021 | 1.380B |
September 30, 2021 | 1.588B |
June 30, 2021 | 1.672B |
March 31, 2021 | 1.010B |
Date | Value |
---|---|
December 31, 2020 | 1.169B |
June 30, 2020 | 465.47M |
December 31, 2019 | 294.66M |
September 30, 2019 | 337.11M |
June 30, 2019 | 393.33M |
June 30, 2019 | 393.33M |
December 31, 2018 | 251.08M |
June 30, 2018 | 198.93M |
June 30, 2018 | 198.93M |
December 31, 2017 | 235.17M |
June 30, 2017 | -71.15M |
June 30, 2017 | -71.15M |
December 31, 2016 | -51.55M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
294.66M
Minimum
Dec 2019
1.672B
Maximum
Jun 2021
1.019B
Average
1.010B
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
Concord Medical Services Holdings Ltd | -294.26M |
WuXi Biologics (Cayman) Inc | 5.594B |
Sinovac Biotech Ltd | 8.649B |
CASI Pharmaceuticals Inc | 9.021M |
Adagene Inc | 56.59M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 987.37M |
Total Liabilities (Quarterly) | 283.19M |
Debt to Equity Ratio | 0.0998 |
Current Ratio | 3.456 |
Net Debt Paydown Yield | -0.83% |